Dr Susan Wyllie
Principal Investigator
Biological Chemistry and Drug Discovery, School of Life Sciences

Contact
Websites
Research
Dr Susan Wyllie has more than 15 years of experience studying kinetoplastid biology. Specifically, her research has focused on determining the mechanisms of action and mechanisms of resistance of drugs targeting kinetoplastid parasites. Her contributions to the research of the Wellcome Centre for Anti-Infectives Research will include:
- Using complementary methodologies in the fields of genomics, chemical proteomics and cell biology to determine the modes of action and specific molecular targets of phenotypically-active compounds
- Developing new genetic and cell biology tools for the study of drug mechanism of action
- Functional characterisation of novel targets
- Developing novel cell-based assays to exploit high value drug targets
Stories
News
Review of the Year 20212 took place last week with the Dean, Julian Blow sharing the highlights of activity within the School from 2022.
News
A team from the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee has developed a new parasite gene-editing technology.

News
Dr Susan Wyllie, Head of the Mode of Action group within WCAIR and Principal Investigator in the School of Life Sciences, underwent a successful tenure review recently.
Research interests
Kinetoplastid Biology
Awards
Award | Year |
---|---|
Innovator of the Year | 2022 |